BIOTRONIK Blog Explore our latest insightful interviews and articles Image Blog Stories Filter and Search Filter by year - Any -20262025202420232022 Search 56 blog articles Image October 1, 2026 From CEO to Patient Advocate How Timo Turned a Life-Changing Diagnosis into a Mission to Help Others Image September 29, 2026 “My ICD Is My Safety Net” How Georg found his way back to life after cardiac arrest and gained greater peace of mind in everyday life. Image September 22, 2026 Looking for Answers After Syncope For many people, a brief dizzy spell, heart flutter, or even a fainting episode seems easy to explain away. Stress, lack of sleep, a busy lifestyle. Oliver thought the same, until a second incident showed him how serious the consequences can be. Image October 25, 2024 Blog BIOTRONIK’s Longstanding Cooperation with Die ARCHE: A Partnership for Children Image December 18, 2025 Blog 25 Years of BIOTRONIK Home Monitoring: The Future of Cardiac Care Began in 2000 What if your cardiologist could spot a problem before you feel it? In 2000, BIOTRONIK made that vision real. With the launch of BIOTRONIK Home Monitoring®, the world’s first telemedicine system for remote follow-up of cardiac implant patients, we helped change how physicians care for people. Image September 23, 2022 Blog The Future of AF Management in ICD Patients How New Strategies Move Beyond Simple AF Detection to Focus on Reducing AF Burden and Monitoring Disease Progression Image February 16, 2023 Blog New German Supply Chain Act Focuses on Human Rights Biotronik’s Chief Procurement Officer Takes a Look at the New Statutory Regulations Image June 23, 2022 Blog “I Now Know What Really Matters in Life” Around 49 million people in the EU suffer from cardiovascular diseases. Here, Coronary Artery Disease (CAD) accounts for the major share of the diseases. In this context, narrowing of vessels by atherosclerotic processes is closely linked to an unhealthy lifestyle. This was also the case for the North Rhine-Westphalian deacon Rainer Beerhenke. After successful stent placement and a bypass surgery in 2021, the 58-year-old is again living life to the full and is one of the first patients to take part in the EU-funded TIMELY project, which aims to improve the range of therapies for CAD patients. Image July 14, 2022 Blog Travelling With a Cardiac Implant is “Easier Than Expected” Rolf Opuchlich has been with the BIOTRONIK Quality Team since 1997. In 2020, he received his own device. Despite knowing just about everything there is to know about the defibrillator he now wears, on his first vacation after getting his implant he was still a bit restless. “I was fairly nervous that first time,” says Rolf looking back at his first flight with his ICD after implantation. “Even though I know our devices well and had everything I needed with me.” Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Next page Next › Subscribe for our News You must have JavaScript enabled to use this form. Title Select TitleMsMrMXDrProf First name Last name Role Please select your roleHealthcare ProfessionalPatient or RelativeJournalistOther Email Phone Country/Region - Select -AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua & BarbudaArgentinaArmeniaArubaAscension IslandAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia & HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCanary IslandsCape VerdeCaribbean NetherlandsCayman IslandsCentral African RepublicCeuta & MelillaChadChileChinaChristmas IslandClipperton IslandCocos (Keeling) IslandsColombiaComorosCongo - BrazzavilleCongo - KinshasaCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d’IvoireDenmarkDiego GarciaDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard & McDonald IslandsHondurasHong Kong SAR ChinaHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKosovoKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacao SAR ChinaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmar (Burma)NamibiaNauruNepalNetherlandsNetherlands AntillesNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorthern Mariana IslandsNorth KoreaNorth MacedoniaNorwayOmanOutlying OceaniaPakistanPalauPalestinian TerritoriesPanamaPapua New GuineaParaguayPeruPhilippinesPitcairn IslandsPolandPortugalPuerto RicoQatarRomaniaRussiaRwandaRéunionSamoaSan MarinoSarkSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia & South Sandwich IslandsSouth KoreaSouth SudanSpainSri LankaSt. BarthélemySt. HelenaSt. Kitts & NevisSt. LuciaSt. MartinSt. Pierre & MiquelonSt. Vincent & GrenadinesSudanSurinameSvalbard & Jan MayenSwedenSwitzerlandSyriaSão Tomé & PríncipeTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad & TobagoTristan da CunhaTunisiaTurkmenistanTurks & Caicos IslandsTuvaluTürkiyeU.S. Outlying IslandsU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVatican CityVenezuelaVietnamWallis & FutunaWestern SaharaYemenZambiaZimbabweÅland Islands Topic Please select a topicProducts (Cardiac Rhythmus Management)Products (Radiation Protection)Products (Electrophysiology)PatientsHealthcare Professionals I prefer to be contacted by Phone Email Message *Fields are mandatory. Latest Press Releases Show all press releases Image August 31, 2026 MUNICH, Germany New Evidence for ICD Decision-Making in Cardiomyopathy Patients with LVEF 36-50% Presented at ESC Congress BIOTRONIK-Supported CMR-GUIDE Trial Evaluates Scar-Based Risk Stratification for ICD Therapy Primary Endpoint Neutral; Secondary Endpoint Shows Reduced Sudden Cardiac Death with ICD Therapy Results from the CMR-GUIDE study were presented by Principal Investigator Prof Dr. Joseph Selvanayagam, Chair of Cardiovascular Medicine at Flinders University, Flinders Medical Centre, Adelaide, Australia, during a Hotline Session at the European Society of Cardiology (ESC) Congress 2026 in Munich, Germany. The findings were also published online in JAMA. Current guidelines generally do not recommend Image July 20, 2026 MIAMI, Florida, USA Press Release BIOTRONIK Neuro Launches Embrace One® Proactive Intelligence, a Proprietary AI Capability that Identifies Emerging Support Needs in SCS Patients BIOTRONIK Neuro today announced the launch of Embrace One ® Proactive Intelligence, a proprietary AI capability that advances proactive care for patients implanted with the Prospera ® Spinal Cord Stimulation (SCS) System. BIOTRONIK Neuro collects more than 200 data points per patient daily through automatic, objective remote monitoring, and the new AI capability analyzes this data to identify early signals that may indicate a patient could benefit from additional support or therapy optimization. The AI model does not make clinical decisions or adjust therapy. Instead, it provides additional Image May 26, 2026 BERLIN, Germany Press Release First European Implants of BIOTRONIK Leadless Pacemaker LivIQ BIOTRONIK, a global leader in medical technology, today announced the first European implantations of its LivIQ leadless pacemaker system as part of the BIO-LivIQ study. The study’s objective is to evaluate the safety and efficacy of LivIQ, including its ability to deliver atrioventricular (AV) synchronous pacing. By enabling AV synchrony at rest and during exercise, LivIQ aims to better address real‑world patient needs, potentially benefiting a broader group of patients, including younger and more active individuals. The procedures were performed by Prof. Christophe Garweg, BIO-LivIQ Steering Press Contact Corporate Public Relations & Communications press@biotronik.com +49 (0) 30 68905 1414 Get in contact
Image October 1, 2026 From CEO to Patient Advocate How Timo Turned a Life-Changing Diagnosis into a Mission to Help Others
Image October 1, 2026 From CEO to Patient Advocate How Timo Turned a Life-Changing Diagnosis into a Mission to Help Others
Image September 29, 2026 “My ICD Is My Safety Net” How Georg found his way back to life after cardiac arrest and gained greater peace of mind in everyday life.
Image September 29, 2026 “My ICD Is My Safety Net” How Georg found his way back to life after cardiac arrest and gained greater peace of mind in everyday life.
Image September 22, 2026 Looking for Answers After Syncope For many people, a brief dizzy spell, heart flutter, or even a fainting episode seems easy to explain away. Stress, lack of sleep, a busy lifestyle. Oliver thought the same, until a second incident showed him how serious the consequences can be.
Image September 22, 2026 Looking for Answers After Syncope For many people, a brief dizzy spell, heart flutter, or even a fainting episode seems easy to explain away. Stress, lack of sleep, a busy lifestyle. Oliver thought the same, until a second incident showed him how serious the consequences can be.
Image October 25, 2024 Blog BIOTRONIK’s Longstanding Cooperation with Die ARCHE: A Partnership for Children
Image October 25, 2024 Blog BIOTRONIK’s Longstanding Cooperation with Die ARCHE: A Partnership for Children
Image December 18, 2025 Blog 25 Years of BIOTRONIK Home Monitoring: The Future of Cardiac Care Began in 2000 What if your cardiologist could spot a problem before you feel it? In 2000, BIOTRONIK made that vision real. With the launch of BIOTRONIK Home Monitoring®, the world’s first telemedicine system for remote follow-up of cardiac implant patients, we helped change how physicians care for people.
Image December 18, 2025 Blog 25 Years of BIOTRONIK Home Monitoring: The Future of Cardiac Care Began in 2000 What if your cardiologist could spot a problem before you feel it? In 2000, BIOTRONIK made that vision real. With the launch of BIOTRONIK Home Monitoring®, the world’s first telemedicine system for remote follow-up of cardiac implant patients, we helped change how physicians care for people.
Image September 23, 2022 Blog The Future of AF Management in ICD Patients How New Strategies Move Beyond Simple AF Detection to Focus on Reducing AF Burden and Monitoring Disease Progression
Image September 23, 2022 Blog The Future of AF Management in ICD Patients How New Strategies Move Beyond Simple AF Detection to Focus on Reducing AF Burden and Monitoring Disease Progression
Image February 16, 2023 Blog New German Supply Chain Act Focuses on Human Rights Biotronik’s Chief Procurement Officer Takes a Look at the New Statutory Regulations
Image February 16, 2023 Blog New German Supply Chain Act Focuses on Human Rights Biotronik’s Chief Procurement Officer Takes a Look at the New Statutory Regulations
Image June 23, 2022 Blog “I Now Know What Really Matters in Life” Around 49 million people in the EU suffer from cardiovascular diseases. Here, Coronary Artery Disease (CAD) accounts for the major share of the diseases. In this context, narrowing of vessels by atherosclerotic processes is closely linked to an unhealthy lifestyle. This was also the case for the North Rhine-Westphalian deacon Rainer Beerhenke. After successful stent placement and a bypass surgery in 2021, the 58-year-old is again living life to the full and is one of the first patients to take part in the EU-funded TIMELY project, which aims to improve the range of therapies for CAD patients.
Image June 23, 2022 Blog “I Now Know What Really Matters in Life” Around 49 million people in the EU suffer from cardiovascular diseases. Here, Coronary Artery Disease (CAD) accounts for the major share of the diseases. In this context, narrowing of vessels by atherosclerotic processes is closely linked to an unhealthy lifestyle. This was also the case for the North Rhine-Westphalian deacon Rainer Beerhenke. After successful stent placement and a bypass surgery in 2021, the 58-year-old is again living life to the full and is one of the first patients to take part in the EU-funded TIMELY project, which aims to improve the range of therapies for CAD patients.
Image July 14, 2022 Blog Travelling With a Cardiac Implant is “Easier Than Expected” Rolf Opuchlich has been with the BIOTRONIK Quality Team since 1997. In 2020, he received his own device. Despite knowing just about everything there is to know about the defibrillator he now wears, on his first vacation after getting his implant he was still a bit restless. “I was fairly nervous that first time,” says Rolf looking back at his first flight with his ICD after implantation. “Even though I know our devices well and had everything I needed with me.”
Image July 14, 2022 Blog Travelling With a Cardiac Implant is “Easier Than Expected” Rolf Opuchlich has been with the BIOTRONIK Quality Team since 1997. In 2020, he received his own device. Despite knowing just about everything there is to know about the defibrillator he now wears, on his first vacation after getting his implant he was still a bit restless. “I was fairly nervous that first time,” says Rolf looking back at his first flight with his ICD after implantation. “Even though I know our devices well and had everything I needed with me.”
Image August 31, 2026 MUNICH, Germany New Evidence for ICD Decision-Making in Cardiomyopathy Patients with LVEF 36-50% Presented at ESC Congress BIOTRONIK-Supported CMR-GUIDE Trial Evaluates Scar-Based Risk Stratification for ICD Therapy Primary Endpoint Neutral; Secondary Endpoint Shows Reduced Sudden Cardiac Death with ICD Therapy Results from the CMR-GUIDE study were presented by Principal Investigator Prof Dr. Joseph Selvanayagam, Chair of Cardiovascular Medicine at Flinders University, Flinders Medical Centre, Adelaide, Australia, during a Hotline Session at the European Society of Cardiology (ESC) Congress 2026 in Munich, Germany. The findings were also published online in JAMA. Current guidelines generally do not recommend
Image August 31, 2026 MUNICH, Germany New Evidence for ICD Decision-Making in Cardiomyopathy Patients with LVEF 36-50% Presented at ESC Congress BIOTRONIK-Supported CMR-GUIDE Trial Evaluates Scar-Based Risk Stratification for ICD Therapy Primary Endpoint Neutral; Secondary Endpoint Shows Reduced Sudden Cardiac Death with ICD Therapy Results from the CMR-GUIDE study were presented by Principal Investigator Prof Dr. Joseph Selvanayagam, Chair of Cardiovascular Medicine at Flinders University, Flinders Medical Centre, Adelaide, Australia, during a Hotline Session at the European Society of Cardiology (ESC) Congress 2026 in Munich, Germany. The findings were also published online in JAMA. Current guidelines generally do not recommend
Image July 20, 2026 MIAMI, Florida, USA Press Release BIOTRONIK Neuro Launches Embrace One® Proactive Intelligence, a Proprietary AI Capability that Identifies Emerging Support Needs in SCS Patients BIOTRONIK Neuro today announced the launch of Embrace One ® Proactive Intelligence, a proprietary AI capability that advances proactive care for patients implanted with the Prospera ® Spinal Cord Stimulation (SCS) System. BIOTRONIK Neuro collects more than 200 data points per patient daily through automatic, objective remote monitoring, and the new AI capability analyzes this data to identify early signals that may indicate a patient could benefit from additional support or therapy optimization. The AI model does not make clinical decisions or adjust therapy. Instead, it provides additional
Image July 20, 2026 MIAMI, Florida, USA Press Release BIOTRONIK Neuro Launches Embrace One® Proactive Intelligence, a Proprietary AI Capability that Identifies Emerging Support Needs in SCS Patients BIOTRONIK Neuro today announced the launch of Embrace One ® Proactive Intelligence, a proprietary AI capability that advances proactive care for patients implanted with the Prospera ® Spinal Cord Stimulation (SCS) System. BIOTRONIK Neuro collects more than 200 data points per patient daily through automatic, objective remote monitoring, and the new AI capability analyzes this data to identify early signals that may indicate a patient could benefit from additional support or therapy optimization. The AI model does not make clinical decisions or adjust therapy. Instead, it provides additional
Image May 26, 2026 BERLIN, Germany Press Release First European Implants of BIOTRONIK Leadless Pacemaker LivIQ BIOTRONIK, a global leader in medical technology, today announced the first European implantations of its LivIQ leadless pacemaker system as part of the BIO-LivIQ study. The study’s objective is to evaluate the safety and efficacy of LivIQ, including its ability to deliver atrioventricular (AV) synchronous pacing. By enabling AV synchrony at rest and during exercise, LivIQ aims to better address real‑world patient needs, potentially benefiting a broader group of patients, including younger and more active individuals. The procedures were performed by Prof. Christophe Garweg, BIO-LivIQ Steering
Image May 26, 2026 BERLIN, Germany Press Release First European Implants of BIOTRONIK Leadless Pacemaker LivIQ BIOTRONIK, a global leader in medical technology, today announced the first European implantations of its LivIQ leadless pacemaker system as part of the BIO-LivIQ study. The study’s objective is to evaluate the safety and efficacy of LivIQ, including its ability to deliver atrioventricular (AV) synchronous pacing. By enabling AV synchrony at rest and during exercise, LivIQ aims to better address real‑world patient needs, potentially benefiting a broader group of patients, including younger and more active individuals. The procedures were performed by Prof. Christophe Garweg, BIO-LivIQ Steering